{"transactions":[{"id":1329445,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T17:00:07.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":18875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested as follows: 1/3rd of the shares subject to the option vested on April 20, 2022; and 1/36th of the shares subject to the option vested monthly over the following two years."}],"balance_after":135896,"derivative":{"exercise_price":9.44,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":18875},"source":{"system":"sec-edgar","filing":"0000950170-24-137316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017024137316/ownership.xml","form_type":"4"}},{"id":1329444,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T17:00:07.000Z","date":"2024-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested as follows: 1/3rd of the shares subject to the option vested on April 20, 2022; and 1/36th of the shares subject to the option vested monthly over the following two years."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":18875},"source":{"system":"sec-edgar","filing":"0000950170-24-137316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017024137316/ownership.xml","form_type":"4"}},{"id":1329443,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T17:00:07.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options."}],"balance_after":101276,"derivative":{"exercise_price":4.11,"exercise_date":"2024-05-25","expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-24-137316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017024137316/ownership.xml","form_type":"4"}},{"id":1329442,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-17T17:00:07.000Z","date":"2024-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options."}],"balance_after":0,"derivative":{"exercise_price":2.84,"exercise_date":"2024-05-25","expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-24-137316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017024137316/ownership.xml","form_type":"4"}},{"id":1498278,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-30T16:10:06.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan)."}],"balance_after":50000,"derivative":{"exercise_price":5,"expiration_date":"2034-05-28","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-066580","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017024066580/ownership.xml","form_type":"4"}},{"id":1705416,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:16.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":18875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on April 20, 2022; and 1/36th of the shares subject to the option vest monthly over the following two years."}],"balance_after":18875,"derivative":{"exercise_price":2.84,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":18875},"source":{"system":"sec-edgar","filing":"0000950170-23-071470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017023071470/ownership.xml","form_type":"4"}},{"id":1705415,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:16.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on April 20, 2022; and 1/36th of the shares subject to the option vest monthly over the following two years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date."}],"balance_after":117021,"derivative":{"exercise_price":9.44,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":18875},"source":{"system":"sec-edgar","filing":"0000950170-23-071470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017023071470/ownership.xml","form_type":"4"}},{"id":1705414,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:16.000Z","date":"2023-12-16","kind":"grant","planned":false,"acquired":true,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":101276,"derivative":{"exercise_price":2.84,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-23-071470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017023071470/ownership.xml","form_type":"4"}},{"id":1705413,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-19T16:05:16.000Z","date":"2023-12-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":101276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on December 16, 2023 (the \"Repricing Date\"). Pursuant to\nthe Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's\nCommon Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":0,"derivative":{"exercise_price":4.11,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0000950170-23-071470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000095017023071470/ownership.xml","form_type":"4"}},{"id":1875251,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-30T20:06:53.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":101276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":101276,"derivative":{"exercise_price":4.11,"expiration_date":"2033-05-24","underlying":"Class A Common Stock","underlying_shares":101276},"source":{"system":"sec-edgar","filing":"0001209191-23-033045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000120919123033045/doc4.xml","form_type":"4"}},{"id":2253966,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T08:30:20.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan)."}],"balance_after":41416,"derivative":{"exercise_price":10.89,"expiration_date":"2032-05-24","underlying":"Class A Common Stock","underlying_shares":41416},"source":{"system":"sec-edgar","filing":"0000899243-22-019855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000089924322019855/doc4.xml","form_type":"4"}},{"id":2547460,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-06T16:11:13.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares subject to the option will vest on October 4, 2022, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":32500,"derivative":{"exercise_price":20.33,"exercise_date":"2022-10-04","expiration_date":"2031-10-04","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001209191-21-059813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000120919121059813/doc4.xml","form_type":"4"}},{"id":4457607,"issuer":{"id":6255,"kind":"organization","name":"Turtle Beach Corp"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-10T16:25:58.000Z","date":"2017-02-03","kind":"disposition_to_issuer","acquired":false,"shares":1599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"As previously reported, these are restricted shares that were granted on January 30, 2014 and were scheduled to vest annually on January 30, 2018.  Also as previously reported, on February 3, 2017, the reporting person resigned from the board of directors of the issuer.  As a result, pursuant to the terms of the award agreement, the shares were forfeited with no compensation due to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As previously reported, these are restricted shares that were granted on January 30, 2014 and were scheduled to vest annually on January 30, 2018.  Also as previously reported, on February 3, 2017, the reporting person resigned from the board of directors of the issuer.  As a result, pursuant to the terms of the award agreement, the shares were forfeited with no compensation due to the reporting person."}],"balance_after":23433,"source":{"system":"sec-edgar","filing":"0001493761-17-000006","document":"wf-form4_148676194492852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000149376117000006/wf-form4_148676194492852.xml","form_type":"4"}},{"id":4457606,"issuer":{"id":6255,"kind":"organization","name":"Turtle Beach Corp"},"owners":[{"id":85006,"kind":"person","name":"DEBUONO LAUREEN","position":1,"cik":"0001034447","reported_name":"DEBUONO LAUREEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-10T16:25:58.000Z","date":"2017-02-03","kind":"disposition_to_issuer","acquired":false,"shares":43103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As previously reported, these are restricted shares that were granted on April 4, 2016 and were scheduled to vest on April 4, 2017.  Also as previously reported, on February 3, 2017, the reporting person resigned from the board of directors of the issuer.  As a result, pursuant to the terms of the award agreement, the shares were forfeited with no compensation due to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As previously reported, these are restricted shares that were granted on April 4, 2016 and were scheduled to vest on April 4, 2017.  Also as previously reported, on February 3, 2017, the reporting person resigned from the board of directors of the issuer.  As a result, pursuant to the terms of the award agreement, the shares were forfeited with no compensation due to the reporting person."}],"balance_after":25032,"source":{"system":"sec-edgar","filing":"0001493761-17-000006","document":"wf-form4_148676194492852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034447/000149376117000006/wf-form4_148676194492852.xml","form_type":"4"}}]}